|
|
Conferences
2010 CDC Diabetes Translation Conference
The Centers for Disease Control and Prevention’s (CDC) Division of Diabetes Translation (DDT) will convene its annual Diabetes Translation Conference April 13-16, 2010, at the Westin Crown Center Hotel, 1 East Pershing Road, Kansas City, Missouri 64108. The conference will bring together
more than 600 participants from a wide range of local, state, federal, and territorial governmental agencies and private-sector diabetes partners.
Call for Late-Breaking Abstracts for the CDC Diabetes Translation
Conference
April 13–16, 2010, Westin Crown Center Hotel, Kansas City, Missouri
“Looking to 2020: Keeping Our Eyes on the Prize of Diabetes Prevention
and Control”
Deadline for submission is March 3, 2010
Late-breaking abstract submission is now open for the Diabetes
Translation Conference, sponsored by the Centers for Disease Control and
Prevention’s Division of Diabetes Translation.
The conference welcomes submission of scientific and programmatic
abstracts that focus on critical issues in diabetes prevention and control
with particular interest in novel effectiveness studies of behavioral health
systems and health policy interventions. Submissions must reflect work
completed after October 30, 2009. The conference will consider late-breaking
abstracts in an oral 15- to 20-minute presentation format.
The deadline for submitting abstracts is March 3, 2010.
Please refer to the original abstract guidance for more information:
http://cdc.confex.com/cdc/cdt2010/cfp.cgi
Contact person: Keshia Jones-Johnson, 678-789-6069,
kjones@visionsusa.net *
Notification of abstract status is anticipated to be provided by March
15, 2010.
Conference Goals
- Explore science, policy, education, program planning,
implementation, and
evaluation to enhance public health approaches and strategies to prevent
and control diabetes.
- Increase knowledge and awareness of successful, cost-effective,
public and private diabetes programs and best practices.
- Present innovative strategies to increase awareness about how to
prevent complications, disabilities, and burden associated with
diabetes.
- Share and showcase effective strategies towards eliminating diabetes-related health disparities.
- Provide opportunities for skill-building, information-sharing, and
networking.
Conference Attendees
2010 CDC’s Diabetes Translation Conference will bring together a wide
range of local, state, federal, and territorial governmental agencies and
private-sector diabetes partners. Our main constituents are the state-based
diabetes prevention and control programs (DPCP), their partners, and the
following:
- Federal, state, and local public health professionals
- Managers, directors, and executives from affiliated health
profession associations
- Health profession associations and consultant partners in prevention
and control activities and programs
- Managers, directors, and executives from health management
organizations
- Health care providers, nutritionists, dieticians, pharmacists, and
diabetes educators
- Vision, kidney, obesity, and chronic disease
partners
- Representatives from special interest groups and industry
- Academic and research staff from educational institutions
- Undergraduate and post-graduate students in public health-related fields
- Policy, media, and communication staff
Abstract Categories
The Conference Planning Committee encourages the submission of abstracts
that address specific issues, approaches, or strategies that contribute to
diabetes prevention and control. Priority preference will be given to
abstracts that describe innovative, crosscutting research and programmatic
initiatives addressing public health’s response to diabetes.
Communication, Media, and Technology
Abstracts demonstrate effective approaches to raise awareness, promote
primary prevention initiatives, empower effective diabetes self-management
strategies, improve health literacy, and reach high-risk populations as they
relate to the prevention and control of diabetes.
Community Intervention
Abstracts describe community interventions focusing on health behaviors
and the environmental factors that influence and affect behavior change. An
intervention may consist of any combination of new programs, changes in
policy, or implementation of alternative practices.
Health Disparities
Abstracts demonstrate applied research strategies and programs to improve
diabetes-related health disparities among racial and ethnic minority and
rural populations.
Epidemiology—Surveillance and Research
Abstracts show strategies for developing and implementing
surveillance data, research studies and economic analysis that can lead to
discussions around the translation of research to applied public health
interventions, and describe the health impact of diabetes.
Evaluation
Abstracts describe program evaluation studies using quantitative and
qualitative data that result in important public health insight for diabetes
prevention and control efforts.
Partnership/Collaboration
Abstracts describe the development, maintenance, and evaluation of
partnerships and collaborations that enhance public health interventions and
initiatives. Examples of what constitutes an effective partnership and
collaborative effort are given. The achievements, challenges, and lessons
learned concerning partnering and collaborating are discussed.
Policy and Legislation
Abstracts describe policies developed and implemented to prevent type 2
diabetes and support the control of diabetes and improve the lives of
people living with diabetes.
Primary Prevention
Abstracts focus on research and public health interventions that expand
the knowledge and community interventions to prevent or delay the onset of
type 2 diabetes.
Public Health System Improvement
Abstracts include examples of patient and provider practices and policies
which improve the quality of diabetes care and treatment.
Abstract Submission Instructions
Please review the information below and pay particular attention to the
instructions given regarding submitting Biographical Data and Conflict of
Interest information.
- Submission Deadline
- Presentation Options
- Test Formats and Requirements
- Evaluation Criteria
- Submission Method
- Confirmation
- Presenter’s Responsibilities
Submission Deadline
To be considered for the conference, all abstracts must be submitted
according to the instructions below by October 30, 2009. No late
abstracts will be accepted for review.
Presentation Options
Four options are available for presentations. Indicate your preference on
the submission form or within the file that is submitted. The options are—
- Oral symposium or special session. This provides a format for
multiple linked presentations on a single topic. Oral symposia/special
sessions will have multiple presenters, all of whom must be identified
prior to submission. The number of presenters, presentations, and length
of each, subject to a limitation of a total time of 60–90 minutes, will
be determined by the proposer. If interested in proposing an oral
symposium or special section, please contact Norma Loner
(nbl1@cdc.gov) for instructions.
Submissions for this type of session will not be accepted through the
usual abstract process.
- Oral panel presentation during concurrent breakout sessions. This is
a single 15- or 20- minute presentation with 5 minutes allotted for
question and answer. One presenter is permitted per abstract (no
exceptions). There may be as many as four abstracts presented during a
90-minute session.
- Training session. This is a 2-hour instructional period on a
specific subject.
- Poster session. This is information presented in poster format
viewed by attendees throughout the entire conference.
Text Formats & Requirements
Format (Abstract will not be accepted if format is not correct.)
- The online abstract submission form will prompt you to cut and paste your
abstract into the following fields: Title, Authors, Objective, Methods,
Results, Conclusion, Learning Objective, and Key Words. Fields are very
important. The field titles do not count in the word limit.
- Use plain text only. Do not use italics, diagrams, boxes, borders, or
tables. No graphics are permitted.
- Active voice is recommended.
- All abbreviations and acronyms must be spelled out when first used.
Length (Section headings are not counted in word or character totals.)
- Make abstract presentation titles no longer than 15 words or 100
characters.
- Make abstract text no more than 250 words or 1,500 characters.
Submission Requirements
In order for your abstract to be eligible for review, it must contain the
following information:
- Abstract submitter’s full contact information as stated on submission form.
- Abstract content (i.e., title, authors, objectives, methods, results,
conclusions, learning objectives, and key words).
- Presenter’s Biographical Data Form (DOC—30KB) (The Professional experience
section must contain between 250 and 400 words).
- Presenter’s Conflict of Interest Disclosure Form (DOC—35KB).
You may download the Biographical Data and Conflict of Interest Disclosure
forms to review the content; however, you will be required to ENTER the
information directly into the online forms.
NOTE: The online abstract system will not allow you to submit your abstract
as final, and subsequently for review, unless ALL of the required
information has been entered into the appropriate sections.
Evaluation Criteria
- Presentation should relate to one or more of the conference categories,
meet the overall goals of the conference, and be of significant public
health importance.
- Purpose/objectives should be clear and well described.
- Work should be performed using rigorous scientific methods
(scientific/epidemiologic related submissions) or should have appropriate
program planning and evaluation methods (programmatic submissions).
- Results or outcomes should be described in the abstract and be relevant to
conference participants.
Submission Method
Abstracts must be submitted electronically through the
conference Web site*
no later than October 30, 2009. An e-mail confirming receipt will be sent to
the submitter immediately. For submission questions contact
Keshia Jones-Johnson,
KJones@VisionsUSA.net.
Confirmation
We will notify abstract submitters of their acceptance status by December
21, 2009. There will be a strict review process of all abstracts received.
We will not accept every abstract for presentation. If the abstract is
accepted, the submitter will receive a request to confirm availability to
attend the conference and make the presentation. The correspondence will
also include information about presentation format, date, and time.
Submitters are responsible for responding to all notices sent by the
conference contractor on behalf of the abstracts.
Presenter’s Responsibilities
- Presenters are responsible for all expenses related to participating in
the conference, including transportation, registration fee, lodging, and
meals.
- Handouts are strongly encouraged for all conference presentations.
- PowerPoint presentations should be sent to the conference contractor prior
to the conference.
- Following the conference, the PowerPoint presentations will be posted
online.
CDC Events and Announcements
CDC Events and Announcements
* Links to non-Federal organizations are provided solely
as a service to our users. Links do not constitute an endorsement of any
organization by CDC or the Federal Government, and none should be inferred.
The CDC is not responsible for the content of the individual organization
Web pages found at this link.
Page last reviewed: January 5, 2010
Page last modified: January 5, 2010
Content Source: National Center for Chronic Disease Prevention and Health Promotion
Division of Diabetes Translation
|
Diabetes & Me